Potential of the NLRP3 inflammasome as a biomarker and therapeutic target in silicosis

Project: Research

Status	Finished
Effective start/end date	1/08/21 → 31/07/24

Toward targeted treatments for silicosis
Barnes, H., Lam, M., Tate, M. D. & Hoy, R., Mar 2024, In: Current Opinion in Pulmonary Medicine. 30, 2, p. 185-194 10 p.
Research output: Contribution to journal › Review Article › Research › peer-review

4 Citations (Scopus)
Aggregated Hendra virus C-protein activates the NLRP3 inflammasome to induce inflammation
Barry, K., Harpur, C., Lam, M., Tate, M. D. & Mansell, A., 10 Nov 2023, In: Journal of Inflammation. 20, 1, 12 p., 38.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

3 Citations (Scopus)
A novel dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseases
Docherty, C. A. H., Fernando, A. J., Rosli, S., Lam, M., Dolle, R. E., Navia, M. A., Farquhar, R., La France, D., Tate, M. D., Murphy, C. K., Rossi, A. G. & Mansell, A., 22 Jun 2023, In: Clinical & Translational Immunology. 12, 6, 18 p., e1455.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

24 Citations (Scopus)

Project Details